Champions Oncology Inc (CSBR)vsRevolution Medicines Inc (RVMD)
CSBR
Champions Oncology Inc
$4.92
+1.86%
HEALTHCARE · Cap: $66.95M
RVMD
Revolution Medicines Inc
$190.27
+0.82%
HEALTHCARE · Cap: $38.14B
Smart Verdict
WallStSmart Research — data-driven comparison
Champions Oncology Inc generates 8075% more annual revenue ($60.66M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -1.9%. RVMD earns a higher WallStSmart Score of 24/100 (F).
CSBR
Avoid23
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+43.2%
Fair Value
$10.38
Current Price
$4.92
$5.46 discount
Intrinsic value data unavailable for RVMD.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Conservative balance sheet, low leverage
Areas to Watch
Trading at 17.6x book value
Smaller company, higher risk/reward
ROE of -53.3% — below average capital efficiency
Earnings declined 61.1%
Trading at 15.6x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : CSBR
CSBR has a balanced fundamental profile.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : CSBR
The primary concerns for CSBR are Price/Book, Market Cap, Return on Equity. Debt-to-equity of 2.82 is elevated, increasing financial risk.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
CSBR profiles as a turnaround stock while RVMD is a value play — different risk/reward profiles.
RVMD carries more volatility with a beta of 1.40 — expect wider price swings.
CSBR is growing revenue faster at 8.8% — sustainability is the question.
CSBR generates stronger free cash flow (-547,000), providing more financial flexibility.
Bottom Line
RVMD scores higher overall (24/100 vs 23/100). CSBR offers better value entry with a 43.2% margin of safety. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Champions Oncology Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Champions Oncology, Inc. develops and sells technology products and solutions to customize the development and use of cancer drugs in the United States. The company is headquartered in Hackensack, New Jersey.
Visit Website →Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?